Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.

Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G508-16. doi: 10.1152/ajpgi.00178.2014. Epub 2014 Jul 10.

2.

Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.

Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR.

Am J Gastroenterol. 2014 Oct;109(10):1621-30. doi: 10.1038/ajg.2014.215. Epub 2014 Jul 29.

PMID:
25070056
3.

A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.

Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ.

Gastroenterology. 2011 Jun;140(7):1934-42. doi: 10.1053/j.gastro.2011.02.063. Epub 2011 Mar 9.

4.

Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.

Camilleri M, Klee EW, Shin A, Carlson P, Li Y, Grover M, Zinsmeister AR.

Am J Physiol Gastrointest Liver Physiol. 2014 Jan 1;306(1):G13-26. doi: 10.1152/ajpgi.00294.2013. Epub 2013 Nov 7.

5.

Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.

Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):1009-15.e3. doi: 10.1016/j.cgh.2012.05.006. Epub 2012 May 18.

6.

Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.

Camilleri M, Carlson P, Acosta A, Busciglio I.

Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G10-20. doi: 10.1152/ajpgi.00080.2015. Epub 2015 Apr 30.

7.

Validating biomarkers of treatable mechanisms in irritable bowel syndrome.

Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR.

Neurogastroenterol Motil. 2014 Dec;26(12):1677-85. doi: 10.1111/nmo.12421. Epub 2014 Sep 22.

8.

Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.

Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR.

Neurogastroenterol Motil. 2011 Nov;23(11):995-9, e458. doi: 10.1111/j.1365-2982.2011.01772.x. Epub 2011 Aug 24.

9.

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.

Shin A, Camilleri M, Vijayvargiya P, Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A, Girtman A, Zinsmeister AR.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1270-1275.e1. doi: 10.1016/j.cgh.2013.04.020. Epub 2013 Apr 30.

10.

Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.

Peleman C, Camilleri M, Busciglio I, Burton D, Donato L, Zinsmeister AR.

Clin Gastroenterol Hepatol. 2017 May;15(5):720-727.e1. doi: 10.1016/j.cgh.2016.11.012. Epub 2016 Nov 14.

11.

Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.

Wong BS, Camilleri M, Carlson PJ, Odunsi-Shiyanbade S, McKinzie S, Busciglio I, Burton D, Zinsmeister AR.

Dig Dis Sci. 2012 May;57(5):1222-6. doi: 10.1007/s10620-012-2035-5. Epub 2012 Jan 21.

12.

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.

Rao AS, Wong BS, Camilleri M, Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P, Lamsam J, Singh R, Zinsmeister AR.

Gastroenterology. 2010 Nov;139(5):1549-58, 1558.e1. doi: 10.1053/j.gastro.2010.07.052. Epub 2010 Aug 4.

13.

Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.

Dior M, Delagrèverie H, Duboc H, Jouet P, Coffin B, Brot L, Humbert L, Trugnan G, Seksik P, Sokol H, Rainteau D, Sabate JM.

Neurogastroenterol Motil. 2016 Sep;28(9):1330-40. doi: 10.1111/nmo.12829. Epub 2016 Apr 5.

PMID:
27060367
14.

Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.

Vijayvargiya P, Busciglio I, Burton D, Donato L, Lueke A, Camilleri M.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):522-527. doi: 10.1016/j.cgh.2017.06.039. Epub 2017 Jun 27.

15.

Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.

Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR.

Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1;304(5):G553-60. doi: 10.1152/ajpgi.00376.2012. Epub 2013 Jan 10.

16.

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, Coffin B, Sabaté JM.

Neurogastroenterol Motil. 2012 Jun;24(6):513-20, e246-7. doi: 10.1111/j.1365-2982.2012.01893.x. Epub 2012 Feb 22.

PMID:
22356587
17.

Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance.

Qin B, Dong L, Guo X, Jiang J, He Y, Wang X, Li L, Zhao J.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2238-46. eCollection 2014.

18.

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.

Camilleri M, Acosta A, Busciglio I, Boldingh A, Dyer RB, Zinsmeister AR, Lueke A, Gray A, Donato LJ.

Aliment Pharmacol Ther. 2015 Mar;41(5):438-48. doi: 10.1111/apt.13065. Epub 2015 Jan 16.

19.

Methods for diagnosis of bile acid malabsorption in clinical practice.

Vijayvargiya P, Camilleri M, Shin A, Saenger A.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1232-9. doi: 10.1016/j.cgh.2013.04.029. Epub 2013 May 2.

20.

Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.

Grasberger H, Chang L, Shih W, Presson AP, Sayuk GS, Newberry RD, Karagiannides I, Pothoulakis C, Mayer E, Merchant JL.

Am J Gastroenterol. 2013 Nov;108(11):1766-74. doi: 10.1038/ajg.2013.304. Epub 2013 Sep 24.

Supplemental Content

Support Center